About Us
Conference+ dedicated to helping young people worldwide achieve great success
Conference+ foundation is a non-profit organization dedicated to helping young people worldwide achieve great success through a unique curriculum.
Wednesday, April 23
The W Hotel, W Nashville 300 12th Avenue South Nashville, TN 37203-4006
SVS continues at full speed with the final innovations that will change the world in which we live, work, and play. Have coffee with the leading university executives who are changing the paradigm of how technologies are commercialized from university and national labs. They’ll be joined by one of the southeast’s most active venture capital investors, who knows a thing or two about the wisdom of backing university spinouts.
Tuesday, April 22
The W Hotel, W Nashville 300 12th Avenue South Nashville, TN 37203-4006
SVS goes full-throttle, with the first round of startups representing the best innovations from the region’s leading universities and national lab. Choose a sector – life sciences or physical sciences – or bounce around between sessions.&nbs
Monday, April 21
The W Hotel, W Nashville 300 12th Avenue South Nashville, TN 37203-4006
The southeast region’s leading research universities and federal laboratories invite you to explore new possibilities at this showcase of groundbreaking, disruptive startups.
Auburn University
Auburn University is a public research university in Auburn, Alabama, whose commercialization path runs through engineering, advanced manufacturing, biomedical systems, and a research park built to move faculty inventions into companies.
Vanderbilt University
Vanderbilt University is a private research university in Nashville whose commercialization path runs through the Center for Technology Transfer and Commercialization, with a record disclosure year and a startup pipeline that already includes companies on the Southeast Venture Showcase stage.
Emory University
Emory University is a private research university in Atlanta whose commercialization path runs through a 40-year technology transfer office, a drug-development fund built on earlier licensing wins, and a startup portfolio that is still mostly active.
Sponsored research awards totaled $1.075 billion in fiscal year 2025, the third consecutive year above $1 billion. Sponsored research expenditures also exceeded $1 billion for the third year in a row.
